Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

Millions of "long COVID" patients coping with debilitating "brain fog" and chronic fatigue, who are looking for answers to ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

In most people with mild to moderate COVID, it can last 7–10 days. Symptomatic people can spread the infection to others from ...

Researchers at the University of Alabama at Birmingham (UAB) have identified what is believed to be the first intervention ...

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...